Filing Pursuant to Rule 424(b)(2)
                                           Registration Statement No. 333-73942



                              PROSPECTUS SUPPLEMENT
                     (TO PROSPECTUS DATED FEBRUARY 12, 2002)

                                 500,000 SHARES

                                 CYBERCARE, INC.

                                  COMMON STOCK

                             -----------------------

      You should read this prospectus supplement and the accompanying prospectus
carefully before you invest. Both documents contain information you should
consider when making your investment decision.

      INVESTING IN CYBERCARE, INC. COMMON STOCK INVOLVES A HIGH DEGREE OF RISK.
SEE "RISK FACTORS" BEGINNING ON PAGE 4 OF OUR PROSPECTUS DATED FEBRUARY 12, 2002
TO READ ABOUT FACTORS YOU SHOULD CONSIDER BEFORE BUYING SHARES OF OUR COMMON
STOCK.

      We sold 500,000 shares of our Common Stock to Strategic Investment
Management, Inc. under the terms of this prospectus supplement. The common stock
was purchased at a purchase price of $0.428 pursuant to the Private Equity Line
Agreement described in the prospectus. On February 20, 2002, the last reported
sale price of our common stock on the Nasdaq National Market was $0.49 per
share.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION OR ANY OTHER STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS
PROSPECTUS SUPPLEMENT IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.


                                ----------------


          The date of this prospectus supplement is February 21, 2002